University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
A Phase Iii Randomised Multi-centre Open-label Study of Active Symptom Control (asc) Alone Or Asc With Oxaliplatin/5-fu Chemotherapy for Patients With Locally Advanced/metastatic Biliary Tract Cancers Previously Treated With Cisplatin / Gemcitabine ChemotherapyView Trial
Accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease: prospective longitudinal study in a multi-ethnic populationView Trial
An open non-randomised study to provide a comparison of data from a conventional blood gas analyser with those obtained from the CE marked Proxima SystemView Trial
The short term effects of an AKT inhibitor (AZD5363) on biomarkers of the AKT pathway and anti-tumour activity in a breast cancer paired biopsy studyView Trial
Scheduling nab-paclItaxEl with GEmcitabine (SIEGE): Randomised phase II trial to investigate two different schedules of nab-paclitaxel (Abraxane) combined with gemcitabine as first line treatment for metastatic pancreatic ductal adenocarcinomaView Trial
Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cellsView Trial
Dissecting mechanisms of regulation of gene expression in human leukaemia.View Trial
Are saccadic eye movements affected by cerebrospinal fluid (CSF) drainage in normal pressure hydrocephalus and might any observed changes be of value in predicting outcome following CSF diversion as a means of treating this condition?View Trial
Sage and Thyme Communication Skills TrainingView Trial
The UK TAVI Trial V1.0
The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial. A multi-centre randomised controlled trial to assess the clinical effectiveness and costutility of TAVI compared with conventional surgical aortic valve replacement in patients with severe symptomatic aortic stenosis at intermediate or high operative riskView Trial